Drugs in the Pipeline Pamrevlumab Fast Tracked for Duchenne Muscular Dystrophy By Brian Park, PharmD Publish Date April 13, 2021
Features Do Successive Transfers of an Emergency Patient Amount to an EMTALA Violation? By Ann W. Latner, JD Publish Date April 12, 2021
Drugs in the Pipeline AbbVie Seeks Approval of Risankizumab for Psoriatic Arthritis By Brian Park, PharmD Publish Date April 7, 2021
Drugs in the Pipeline FDA Panel Votes on Tanezumab for Osteoarthritis Pain By Diana Ernst, RPh Publish Date March 29, 2021
News Guselkumab Benefits Observed Through 2 Years in Psoriatic Arthritis Trial By Diana Ernst, RPh Publish Date March 17, 2021
News Long-Term Data Demonstrate Sustained Efficacy of Risdiplam in Spinal Muscular Atrophy By Diana Ernst, RPh Publish Date March 16, 2021
News Zolgensma Benefits Observed in Presymptomatic SMA Patients By Brian Park, PharmD Publish Date March 15, 2021
News Actemra Gains New Indication for Systemic Sclerosis-Associated Interstitial Lung Disease By Steve Duffy Publish Date March 5, 2021
News Amondys 45 Approved for Duchenne Muscular Dystrophy By Lea Eslava-Kim, PharmD Publish Date February 26, 2021
News Fatigue Assessment Included in Simponi Aria Labeling By Diana Ernst, RPh Publish Date February 22, 2021
News FDA Approves 3D Printed Implant for Avascular Necrosis of the Talus By Brian Park, PharmD Publish Date February 18, 2021
News Managing RA: Consider Potential Interactions With JAK Inhibitors By Cassandra Pardini, PharmD Publish Date February 17, 2021
News WellDyne to Provide Physician Access to Scipher Medicine’s PrismRA Blood Test By Brian Park, PharmD Publish Date February 11, 2021
News Tofacitinib vs TNFi for RA: Safety Study Results Announced By Brian Park, PharmD Publish Date January 27, 2021
News Digital Health App Tracks Pain Progress With Neurostimulation Therapy By Brian Park, PharmD Publish Date January 14, 2021
Drugs in the Pipeline Locally-Delivered Sitaxsentan Designated Orphan Drug for Systemic Sclerosis By Brian Park, PharmD Publish Date January 13, 2021